Rescuing drug discovery: in vivo systems pathology and systems pharmacology

被引：0

作者：

Jan van der Greef

Robert N. McBurney

机构：

[1] TNO Systems Biology,

[2] Netherlands Organization for Applied Scientific Research,undefined

[3] Utrechtseweg 48,undefined

[4] PO BOX 360,undefined

[5] Centre for Medical Systems Biology/Leiden Amsterdam Centre for Drug Research,undefined

[6] Einsteinweg 55,undefined

[7] PO BOX 9502,undefined

[8] BG Medicine,undefined

[9] Inc.,undefined

[10] BG Medicine,undefined

[11] Inc.,undefined

来源：

Nature Reviews Drug Discovery | 2005年 / 4卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The pharmaceutical industry is currently beleaguered by close scrutiny from the financial community, regulators and the general public. Productivity, in terms of new drug approvals, has generally been falling for almost a decade and the safety of a number of highly successful drugs has recently been brought into question. Here, we discuss whether taking an in vivo systems approach to drug discovery and development could be the paradigm shift that rescues the industry.

引用

页码：961 / 967

页数：6

共 62 条

[41] Tawara JN(undefined)undefined undefined undefined undefined-undefined
[42] Zenewicz LA(undefined)undefined undefined undefined undefined-undefined
[43] Lewis K(undefined)undefined undefined undefined undefined-undefined
[44] Sengupta S(undefined)undefined undefined undefined undefined-undefined
[45] Wang M(undefined)undefined undefined undefined undefined-undefined
[46] Szegedi A(undefined)undefined undefined undefined undefined-undefined
[47] Kohnen R(undefined)undefined undefined undefined undefined-undefined
[48] Dienel A(undefined)undefined undefined undefined undefined-undefined
[49] Kieser M(undefined)undefined undefined undefined undefined-undefined
[50] Ogawa N(undefined)undefined undefined undefined undefined-undefined

← 1 2 3 4 5 6 7 →